Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients. outcomes and prognostic factors after long-term follow-up
BACKGROUND:
We evaluated a series of oligometastatic colorectal cancer (CRC) patients treated with stereotactic ablative body radiotherapy (SABR) delivered in all active lung metastases.
PATIENTS AND METHODS:
Forty-four patients with 69 lung metastases were treated with SABR. Eleven patients presented with other sites of metastases before stereotactic body radiotherapy (SBRT), even though they had controlled/cured systemic disease.
RESULTS: